[35S]GTPγS Binding Assay

AB Alessandro Bonifazi
AN Amy H. Newman
TK Thomas M. Keck
SG Silvia Gervasoni
GV Giulio Vistoli
GG Gianfabio Giorgioni
PP Pegi Pavletić
AP Alessandro Piergentili
request Request a Protocol
ask Ask a question
Favorite

The effects of the various compounds tested on [35S]GTPγS binding in HeLa cells expressing the recombinant human 5-HT1AR were evaluated according to the method of Stanton and Beer [41] with minor modifications. The stimulation experiments are as follows: Cell membranes (50–70 μg of protein) were resuspended in buffer containing 20 mM HEPES, 3 mM MgSO4, and 120 mM NaCl (pH 7.4). The membranes were incubated with 30 μM GDP and various concentrations (from 0.1 nM to 10 μM) of test drugs or 8-OH-DPAT (reference curve) for 20 min at 30 °C in a final volume of 0.5 mL. The samples were transferred to ice, [35S]GTPγS (200 pM) was added, and the samples were incubated for further 30 min at 30 °C. The preincubation with both agonist and antagonist, before initiating the [35S]GTPγS binding, ensures that agonist and antagonist are at equilibrium. Nonspecific binding was determined in the presence of 10 mM GTPγS. Incubation was stopped by the addition of ice-cold HEPES buffer and rapid filtration on Unifilter B filters (PerkinElmer) using a Filtermate cell harvester (Packard). The filters were washed with ice-cold Hepes buffer, and the radioactivity retained on the filters was determined by a TopCount, PerkinElmer liquid scintillation counter at 90% efficiency.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A